Sang-Hyun Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sang-Hyun Kim has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Chong-Kil Lee
Department of Pharmaceutics, College of Pharmacy, Chungbuk National University, Cheongju 28644, Korea
8 shared publications - Chun-Woong Park
College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea
7 shared publications - Jeong-Ki Kim
College of Pharmacy, Korea University, Sejong 30019, Korea
7 shared publications - Bill Thaddeus Padasas
Department of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea
5 shared publications - Erica Españo
Department of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Korea
4 shared publications - Jun-Hyeok Moon
Department of Pharmaceutics, College of Pharmacy, Chungbuk National University, Cheongju 28644, Korea
3 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 14 (5)
Inhibition of viral infection via adsorption-driven physical sequestration by natural illite: A sustainable, broad-spectrum antiviral material
- 18 August 2026
- Published by Elsevier in Journal of Environmental Chemical Engineering
- Vol. 14 (5)
Open AccessInhibition of viral infection via adsorption-driven physical sequestration by natural illite: A sustainable, broad-spectrum antiviral material
- Open Access
- 31 March 2026
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 10 (1) , 1-9
Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation
Major histocompatibility complex (MHC)-restricted antigen presentation is a fundamental process that initiates and shapes T cell-mediated immune responses. While most current immunomodulatory therapies target downstream signaling pathways of T cell activation, growing evidence highlights antigen presentation as a critical upstream determinant of T cell specificity, magnitude, and functional outcome. Pharmacological agents that modulate antigen processing, peptide loading, and MHC surface expression can profoundly alter T cell priming and immune responses. In this review, we briefly summarize the molecular mechanisms governing MHC class I- and class II-restricted antigen presentation, including cross-presentation by professional antigen-presenting cells. We then discuss emerging pharmacological modulators that regulate T cell responses by targeting MHC-restricted antigen presentation pathways, including calcineurin inhibitors, proteasome and immunoproteasome inhibitors, epigenetic regulators, endoplasmic reticulum stress modulators, and autophagy-targeting agents. By highlighting how these agents influence antigen processing and presentation independently of direct T cell signaling, we propose pharmacological modulation of MHC-restricted antigen presentation as an underexplored yet powerful strategy for immune intervention.
- 31 March 2026
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 10 (1) , 1-9
Open AccessRegulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation
Major histocompatibility complex (MHC)-restricted antigen presentation is a fundamental process that initiates and shapes T cell-mediated immune responses. While most current immunomodulatory therapies target downstream signaling pathways of T cell activation, growing evidence highlights antigen presentation as a critical upstream determinant of T cell specificity, magnitude, and functional outcome. Pharmacological agents that modulate antigen processing, peptide loading, and MHC surface expression can profoundly alter T cell priming and immune responses. In this review, we briefly summarize the molecular mechanisms governing MHC class I- and class II-restricted antigen presentation, including cross-presentation by professional antigen-presenting cells. We then discuss emerging pharmacological modulators that regulate T cell responses by targeting MHC-restricted antigen presentation pathways, including calcineurin inhibitors, proteasome and immunoproteasome inhibitors, epigenetic regulators, endoplasmic reticulum stress modulators, and autophagy-targeting agents. By highlighting how these agents influence antigen processing and presentation independently of direct T cell signaling, we propose pharmacological modulation of MHC-restricted antigen presentation as an underexplored yet powerful strategy for immune intervention.
- Open Access
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (4)
Conserved Influenza Epitopes Delivered via MHC-I–Functionalized Nanocarriers Induce Influenza-Specific CTL Responses
Kim SH, et al. Immune Netw. 2026 Aug;26(4):e30. https://doi.org/10.4110/in.2026.26.e30
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (4)
Open AccessConserved Influenza Epitopes Delivered via MHC-I–Functionalized Nanocarriers Induce Influenza-Specific CTL Responses
Kim SH, et al. Immune Netw. 2026 Aug;26(4):e30. https://doi.org/10.4110/in.2026.26.e30
- Open Access
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (3) , e20
Programmable Bacterial Contractile Injection Systems for Ag Delivery and CD8 + T Cell Activation
- 1 January 2026
- Published by XMLink in Immune Network
- Vol. 26 (3) , e20
Open AccessProgrammable Bacterial Contractile Injection Systems for Ag Delivery and CD8 + T Cell Activation
- Open Access
Teicoplanin attenuates RNA virus infection in vitro
Teicoplanin (TP) is a glycopeptide antibiotic used for Gram-positive bacterial infections, and it has been reported to inhibit SARS-CoV-2 and Ebola virus entry through cathepsin inhibition. Given that TP can inhibit viruses belonging to different virus families, we aimed to expand the potential targets of TP to determine whether TP can be developed as a broad-spectrum antiviral agent. Considering the original indication of TP, we first determined the effects of TP against viruses that cause respiratory tract infections and found that TP inhibits enveloped and non-enveloped RNA viruses, namely: human and avian influenza viruses; representative coronaviruses including porcine epidemic diarrhea virus (PEDV), human coronavirus OC43 (HCoV-OC43), and SARS-CoV-2; measles virus; human respiratory syncytial virus A2; and enterovirus 71 (EV-71). Representative flaviviruses, Zika virus (ZIKV) and dengue virus serotype 2 (DENV2), were also susceptible to inhibition by TP. In contrast, TP did not attenuate infection of human adenovirus 5, a non-enveloped DNA virus. Addition of TP at the endocytosis stage but not at the attachment/binding stage of PEDV infection reduced PEDV production in vitro , indicating cathepsin inhibition. Meanwhile, addition of TP during either the attachment/binding or the endocytosis stage of ZIKV infection reduced ZIKV particle production in host cells, and in silico modeling suggested that TP has potential binding pockets in the envelope proteins of ZIKV and DENV2. These results show that TP can be developed as a broad-spectrum antiviral especially against RNA viruses, with potentially different targets in the replication cycle of various viruses.
Open AccessTeicoplanin attenuates RNA virus infection in vitro
Teicoplanin (TP) is a glycopeptide antibiotic used for Gram-positive bacterial infections, and it has been reported to inhibit SARS-CoV-2 and Ebola virus entry through cathepsin inhibition. Given that TP can inhibit viruses belonging to different virus families, we aimed to expand the potential targets of TP to determine whether TP can be developed as a broad-spectrum antiviral agent. Considering the original indication of TP, we first determined the effects of TP against viruses that cause respiratory tract infections and found that TP inhibits enveloped and non-enveloped RNA viruses, namely: human and avian influenza viruses; representative coronaviruses including porcine epidemic diarrhea virus (PEDV), human coronavirus OC43 (HCoV-OC43), and SARS-CoV-2; measles virus; human respiratory syncytial virus A2; and enterovirus 71 (EV-71). Representative flaviviruses, Zika virus (ZIKV) and dengue virus serotype 2 (DENV2), were also susceptible to inhibition by TP. In contrast, TP did not attenuate infection of human adenovirus 5, a non-enveloped DNA virus. Addition of TP at the endocytosis stage but not at the attachment/binding stage of PEDV infection reduced PEDV production in vitro , indicating cathepsin inhibition. Meanwhile, addition of TP during either the attachment/binding or the endocytosis stage of ZIKV infection reduced ZIKV particle production in host cells, and in silico modeling suggested that TP has potential binding pockets in the envelope proteins of ZIKV and DENV2. These results show that TP can be developed as a broad-spectrum antiviral especially against RNA viruses, with potentially different targets in the replication cycle of various viruses.
- Open Access
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (3) , e19
Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines
Kim SH, et al. Immune Netw. 2024 May;24(3):e19. https://doi.org/10.4110/in.2024.24.e19
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (3) , e19
Open AccessInfluenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines
Kim SH, et al. Immune Netw. 2024 May;24(3):e19. https://doi.org/10.4110/in.2024.24.e19
- Open Access
- 1 January 2023
- Published by XMLink in Food Supplements and Biomaterials for Health
- Vol. 3 (2)
Pharmacological and Therapeutic Activities of Aloe vera and Its Major Active Constituent Acemannan
Aloe vera, a medicinal herb with a lengthy history in traditional and folk medicine, is widely used today as a common ingredient in various healthcare and beauty products. Extensive research has been conducted to verify its therapeutic effectiveness, understand its mechanisms, and identify the active components responsible for its properties. The plant has been found to possess numerous biological properties, including immune system regulation, anti-inflammatory effects, promotion of wound healing, potential anticancer activity, antiviral properties, management of diabetes, and protection against radiation. While the polysaccharides present in the inner gel, particularly acemannan, have been credited for many of therapeutic effects of A. vera, other constituents such as lectins, alkaloids, anthraquinones, anthrones, chromones, coumarins, and polyphenols also contribute to its diverse and numerous benefits. In this review, we focus on acemannan, a well-studied polysaccharide extracted from A. vera gel, while highlighting the recently discovered effects and applications of this remarkable plant.
- 1 January 2023
- Published by XMLink in Food Supplements and Biomaterials for Health
- Vol. 3 (2)
Open AccessPharmacological and Therapeutic Activities of Aloe vera and Its Major Active Constituent Acemannan
Aloe vera, a medicinal herb with a lengthy history in traditional and folk medicine, is widely used today as a common ingredient in various healthcare and beauty products. Extensive research has been conducted to verify its therapeutic effectiveness, understand its mechanisms, and identify the active components responsible for its properties. The plant has been found to possess numerous biological properties, including immune system regulation, anti-inflammatory effects, promotion of wound healing, potential anticancer activity, antiviral properties, management of diabetes, and protection against radiation. While the polysaccharides present in the inner gel, particularly acemannan, have been credited for many of therapeutic effects of A. vera, other constituents such as lectins, alkaloids, anthraquinones, anthrones, chromones, coumarins, and polyphenols also contribute to its diverse and numerous benefits. In this review, we focus on acemannan, a well-studied polysaccharide extracted from A. vera gel, while highlighting the recently discovered effects and applications of this remarkable plant.
- Open Access
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (2)
COVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Padasas BT, et al. Immune Netw. 2023 Mar;23(2):e13. https://doi.org/10.4110/in.2023.23.e13
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (2)
Open AccessCOVID-19 Therapeutics: An Update on Effective Treatments Against Infection With SARS-CoV-2 Variants
Padasas BT, et al. Immune Netw. 2023 Mar;23(2):e13. https://doi.org/10.4110/in.2023.23.e13
- Open Access
- 25 October 2022
- Published by XMLink in Immune Network
- Vol. 22 (5) , e42
Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody
Kim SH, et al. Immune Netw. 2022 Oct;22(5):e42. https://doi.org/10.4110/in.2022.22.e42
- 25 October 2022
- Published by XMLink in Immune Network
- Vol. 22 (5) , e42
Open AccessEfficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody
Kim SH, et al. Immune Netw. 2022 Oct;22(5):e42. https://doi.org/10.4110/in.2022.22.e42
- 31 March 2022
- Published by Korean Food Marketing Association in Korean Journal of Food Mareting Econmics
- Vol. 39 (1) , 47-62
Analysis of Determinants of Export of Six Major Fruit
This study identifies export determinants by constructing panel data related to the export of the six major fruits(apples, pears, peaches, grapes, tangerines, sweet persimmons) from 2005 to 2020. To this end, an export equation with export volume by fruit as a dependent variable is set, and recent fruit supply and trade conditions are included in the explanatory variable as the previous studies. As a result of empirical analysis through the fixed-effect model, the relative prices(wholesale price / export price), production, GDP per capita in the exporting country, number of exporting countries, labor cost share, and distribution margin rate have significant impacts on fruit exports. Based on these analysis results, strategies and measures to enhance the export competitiveness of six major fruits are presented. More FTAs to be signed in the future could be an opportunity to increase exports of Korean fruits. In addition, it is important to improve export competitiveness because an increase in fruit exports can lead to an increase in the income of fruit farmers. Therefore, specific empirical research and effective policy support should be continued.
- 31 March 2022
- Published by Korean Food Marketing Association in Korean Journal of Food Mareting Econmics
- Vol. 39 (1) , 47-62
Analysis of Determinants of Export of Six Major Fruit
This study identifies export determinants by constructing panel data related to the export of the six major fruits(apples, pears, peaches, grapes, tangerines, sweet persimmons) from 2005 to 2020. To this end, an export equation with export volume by fruit as a dependent variable is set, and recent fruit supply and trade conditions are included in the explanatory variable as the previous studies. As a result of empirical analysis through the fixed-effect model, the relative prices(wholesale price / export price), production, GDP per capita in the exporting country, number of exporting countries, labor cost share, and distribution margin rate have significant impacts on fruit exports. Based on these analysis results, strategies and measures to enhance the export competitiveness of six major fruits are presented. More FTAs to be signed in the future could be an opportunity to increase exports of Korean fruits. In addition, it is important to improve export competitiveness because an increase in fruit exports can lead to an increase in the income of fruit farmers. Therefore, specific empirical research and effective policy support should be continued.